Fintel reports that on March 12, 2025, Wedbush downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Outperform to ...

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...

Despite the recent rash of tech stock sell-offs, the analysts at Wedbush believe this is a short-term phenomenon, and the ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...

Wedbush reaffirmed their outperform rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a research note ...

Just days after saying Tesla Inc.’s recent stock selloff was overdone, Wedbush analyst Dan Ives, a well-known tech analyst ...

Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...

Tesla (TSLA) stock has landed on Wedbush’s “best ideas list” as analyst Daniel Ives reaffirmed his bullish stance on the ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...

Tesla stock is gaining ground on the heels of two significant news items today. President Trump made a statement of support for the company and its CEO, Elon Musk, and Wedbush put out analysis ...

Markets are still under a great deal of pressure. All thanks to more tariffs on Canada, Mexico, China and inflation threats, ...